Skip to main content

Aroa Soriano Fernández

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Aroa Soriano Fernández

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

JARC: Joint Action on Rare Cancers Grant Agreement: 724161 VHIR involved in WP9 Task 2 : Objective Use of relevant paediatric preclinical models (patients derived xenografts, genetically modified models, other preclinical model) for experimental therapeutics contributes to choosing the drugs to develop in children. These models have been developed by many research teams in Europe. There is a need to draw a consolidated list of models and teams to facilitate the use of these models and speed up innovation.

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, Aroa Soriano Fernández, Josep Roma Castanyer
Funding agency: Ex. Agency for Health Consumers (EAHC)-CHAFEA
Funding: 6959.28
Reference: JARC_3HP-CHAFEA2015
Duration: 01/10/2016 - 30/09/2019

Investigació translacional en càncer infantil (GRE)

IP: Investigació translacional en càncer infantil (GRE)
Collaborators: Soledad Gallego Melcón, Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Anna Llort Sales, Raquel Hladun Alvaro, Laura Alonso Garcia, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 30000
Reference: 2014 SGR 660
Duration: 01/01/2014 - 31/12/2016

Nanoterapia basada en microRNAs: nuevo tratamiento para tumores pediátricos del sistema nervioso

IP: Miguel Segura Ginard
Collaborators: Luís Gros Subias, Aroa Soriano Fernández, Nanoterapia basada en microRNAs: nuevo tratamiento para tumores pediátricos del sistema nervioso, Constantino Sábado Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 116765
Reference: PI14/00561
Duration: 01/01/2015 - 31/12/2017

TERAPIA PERSONALIZADA CONTRA ERK5 EN NEUROBLASTOMA

IP: Aroa Soriano Fernández
Collaborators: Soledad Gallego Melcón, Miguel Segura Ginard
Funding agency: Asociación Española Contra el Cáncer
Funding: 20000
Reference: 2014/AECC-JB/SORIANO
Duration: 31/01/2015 - 31/01/2017

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Vall d'Hebron is one of the centers that coordinate this network, which so far has enabled the detection of high-risk genetic alterations and the provision of personalized treatments that have already achieved remission in cases with very few therapeutic alternatives.

The projects, selected under the 2026 Health Research and CaixaImpulse Health Innovation calls, address topics ranging from new therapies for childhood neurological disorders and Parkinson’s disease to the treatment of mitochondrial diseases and cancer.

Related professionals

Breogan Rodriguez Acevedo

Breogan Rodriguez Acevedo

Senior researcher
Clinical Neuroimmunology
Read more
Jacques Planas Morin

Jacques Planas Morin

Senior researcher
Biomedical Research in Urology
Read more
Miquel Masachs Peracaula

Miquel Masachs Peracaula

Postdoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Ines Mercedes Oliveira Souto

Ines Mercedes Oliveira Souto

Main researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.